Harmony Asset Management’s Gilead Sciences GILD Stock Holding History

Harmony Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572K	Buy	4,524 +19	+0.4%	+$2.5K	0.15%	120
2026 Q1	$628K	Buy	4,505 +618	+16%	+$86.5K	0.19%	109
2025 Q4	$477K	Buy	3,887 +36	+0.9%	+$4.38K	0.16%	114
2025 Q3	$427K	Buy	3,851 +27	+0.7%	+$3.07K	0.15%	122
2025 Q2	$424K	Buy	3,824 +28	+0.7%	+$2.98K	0.16%	121
2025 Q1	$425K	Sell	3,796 -93	-2%	-$9.6K	0.18%	114
2024 Q4	$359K	Sell	3,889 -569	-13%	-$51.2K	0.14%	122
2024 Q3	$374K	Buy	4,458 +634	+17%	+$48.4K	0.14%	122
2024 Q2	$262K	Buy	+3,824	New	+$255K	0.11%	138

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Harmony Asset Management's GILD Position: Q2 2026 in Review

Harmony Asset Management increased its Gilead Sciences (GILD) stake by 0.42% in Q2 2026, buying an estimated $2.5K and bringing the position to 4,524 shares worth $572K. The position accounts for 0.15% of the portfolio, ranked #120.

Harmony Asset Management first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $628K in Q1 2026. 408 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Harmony Asset Management held 4,524 shares of Gilead Sciences worth $572K as of Q2 2026.
Harmony Asset Management bought 19 Gilead Sciences shares in Q2 2026, an estimated $2.5K.
Gilead Sciences made up 0.15% of Harmony Asset Management's portfolio in Q2 2026, its #120 holding.
Harmony Asset Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Harmony Asset Management's Gilead Sciences position peaked at $628K in Q1 2026.
408 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.